Mucormycosis in a renal transplant recipient: Case Report and comprehensive review of literature

Tamim Hamdi, Vanji Karthikeyan, George J. Alangaden

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Mucormycosis is a rare but devastating infection. We present a case of fatal disseminated mucormycosis infection in a renal transplant patient. Uncontrolled diabetes mellitus and immunosuppression are the major predisposing factors to infection with Mucorales. Mucorales are angioinvasive and can infect any organ system. Lungs are the predominant site of infection in solid organ transplant recipients. Prompt diagnosis is challenging and influences outcome. Treatment involves a combination of surgical and medical therapies. Amphotericin B remains the cornerstone in the medical management of mucormycosis, although other agents have been used. Newer agents are promising.

Original languageEnglish (US)
Article number950643
JournalInternational Journal of Nephrology
Volume2014
DOIs
StatePublished - 2014

Fingerprint

Mucormycosis
Mucorales
Kidney
Infection
Transplants
Amphotericin B
Causality
Immunosuppression
Diabetes Mellitus
Lung
Transplant Recipients
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Mucormycosis in a renal transplant recipient : Case Report and comprehensive review of literature. / Hamdi, Tamim; Karthikeyan, Vanji; Alangaden, George J.

In: International Journal of Nephrology, Vol. 2014, 950643, 2014.

Research output: Contribution to journalArticle

@article{79c436b5cc464b7491e82378eed4a1a3,
title = "Mucormycosis in a renal transplant recipient: Case Report and comprehensive review of literature",
abstract = "Mucormycosis is a rare but devastating infection. We present a case of fatal disseminated mucormycosis infection in a renal transplant patient. Uncontrolled diabetes mellitus and immunosuppression are the major predisposing factors to infection with Mucorales. Mucorales are angioinvasive and can infect any organ system. Lungs are the predominant site of infection in solid organ transplant recipients. Prompt diagnosis is challenging and influences outcome. Treatment involves a combination of surgical and medical therapies. Amphotericin B remains the cornerstone in the medical management of mucormycosis, although other agents have been used. Newer agents are promising.",
author = "Tamim Hamdi and Vanji Karthikeyan and Alangaden, {George J.}",
year = "2014",
doi = "10.1155/2014/950643",
language = "English (US)",
volume = "2014",
journal = "International Journal of Nephrology",
issn = "2090-214X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Mucormycosis in a renal transplant recipient

T2 - Case Report and comprehensive review of literature

AU - Hamdi, Tamim

AU - Karthikeyan, Vanji

AU - Alangaden, George J.

PY - 2014

Y1 - 2014

N2 - Mucormycosis is a rare but devastating infection. We present a case of fatal disseminated mucormycosis infection in a renal transplant patient. Uncontrolled diabetes mellitus and immunosuppression are the major predisposing factors to infection with Mucorales. Mucorales are angioinvasive and can infect any organ system. Lungs are the predominant site of infection in solid organ transplant recipients. Prompt diagnosis is challenging and influences outcome. Treatment involves a combination of surgical and medical therapies. Amphotericin B remains the cornerstone in the medical management of mucormycosis, although other agents have been used. Newer agents are promising.

AB - Mucormycosis is a rare but devastating infection. We present a case of fatal disseminated mucormycosis infection in a renal transplant patient. Uncontrolled diabetes mellitus and immunosuppression are the major predisposing factors to infection with Mucorales. Mucorales are angioinvasive and can infect any organ system. Lungs are the predominant site of infection in solid organ transplant recipients. Prompt diagnosis is challenging and influences outcome. Treatment involves a combination of surgical and medical therapies. Amphotericin B remains the cornerstone in the medical management of mucormycosis, although other agents have been used. Newer agents are promising.

UR - http://www.scopus.com/inward/record.url?scp=84897789671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897789671&partnerID=8YFLogxK

U2 - 10.1155/2014/950643

DO - 10.1155/2014/950643

M3 - Article

C2 - 24688793

AN - SCOPUS:84897789671

VL - 2014

JO - International Journal of Nephrology

JF - International Journal of Nephrology

SN - 2090-214X

M1 - 950643

ER -